Stockscreener 앱 받기
325.21
0.40%
1.45
전일 마감가:
$323.76
열려 있는:
$323.87
하루 거래량:
31,958
Relative Volume:
0.09
시가총액:
$12.81B
수익:
$1.45B
순이익/손실:
$171.05M
주가수익비율:
74.83
EPS:
4.3459
순현금흐름:
$212.73M
1주 성능:
-0.60%
1개월 성능:
+2.41%
6개월 성능:
-4.22%
1년 성능:
+29.31%
1일 변동 폭
$323.87
$325.15
1주일 범위
$323.76
$328.60
52주 변동 폭
$221.26
$362.41
Penumbra Inc Stock (PEN) Company Profile
명칭
Penumbra Inc
전화
(510) 995-2486
주소
ONE PENUMBRA PLACE, ALAMEDA, CA
Compare PEN vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PEN
Penumbra Inc
|
325.15 | 12.87B | 1.45B | 171.05M | 212.73M | 4.3459 |
ABT
Abbott Laboratories
|
116.11 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
329.97 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
93.16 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
50.40 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.19 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Penumbra Inc Stock (PEN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-18 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2025-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-11-18 | 개시 | Wells Fargo | Underweight |
| 2025-10-08 | 업그레이드 | Needham | Hold → Buy |
| 2025-09-02 | 개시 | Evercore ISI | Outperform |
| 2025-03-14 | 개시 | BofA Securities | Buy |
| 2025-01-21 | 개시 | UBS | Buy |
| 2024-12-17 | 개시 | Oppenheimer | Outperform |
| 2024-12-11 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-09-18 | 개시 | Stifel | Buy |
| 2024-09-03 | 개시 | Leerink Partners | Outperform |
| 2024-07-31 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-07-31 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-02-23 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2023-09-06 | 개시 | Morgan Stanley | Equal-Weight |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-03-29 | 다운그레이드 | Needham | Buy → Hold |
| 2023-01-30 | 개시 | Piper Sandler | Overweight |
| 2022-11-04 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-10-05 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-09-09 | 업그레이드 | Needham | Hold → Buy |
| 2022-07-18 | 개시 | RBC Capital Mkts | Outperform |
| 2022-04-19 | 개시 | Deutsche Bank | Buy |
| 2022-03-08 | 개시 | Needham | Hold |
| 2021-09-16 | 개시 | Truist | Buy |
| 2021-06-04 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2020-12-16 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2020-10-07 | 재개 | Canaccord Genuity | Buy |
| 2020-09-29 | 개시 | BTIG Research | Buy |
| 2020-09-08 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2019-06-13 | 재확인 | BofA/Merrill | Buy |
| 2019-05-30 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2019-05-21 | 개시 | William Blair | Outperform |
| 2018-10-29 | 재개 | BofA/Merrill | Buy |
| 2018-10-08 | 개시 | RBC Capital Mkts | Outperform |
| 2018-02-21 | 개시 | William Blair | Outperform |
| 2018-01-02 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2015-11-30 | 재확인 | Canaccord Genuity | Buy |
| 2015-10-13 | 개시 | Wells Fargo | Outperform |
모두보기
Penumbra Inc 주식(PEN)의 최신 뉴스
Trillium Asset Management LLC Acquires New Stake in Penumbra, Inc. $PEN - MarketBeat
BlackRock Inc. Invests $1.36 Billion in Penumbra, Inc. $PEN - MarketBeat
Incuvate Says Penumbra Infringed Blood Clot Detection System (1) - Bloomberg Law News
Penumbra, Inc. (NYSE:PEN) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Penumbra (NYSE: PEN) grants president 3,060 RSUs with multi-year vesting - Stock Titan
Penumbra (PEN) Results at a Glance: Reported EPS Misses Expectations for This Review; Trading-Day Reaction: The Share Price Sheds 0.74% in the Available RecordForward Guidance Trends - Vinanet
NINE MASTS CAPITAL Ltd Acquires New Position in Penumbra, Inc. $PEN - MarketBeat
Citizens Financial Group Inc. RI Invests $9.88 Million in Penumbra, Inc. $PEN - MarketBeat
Penumbra, Inc. (PEN) Stock Analysis: Exploring a 10.65% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Fidelity Advisor Mid Cap II Fund's Penumbra Inc(PEN) Holding History - GuruFocus
Alberta Investment Management Corp Invests $10.46 Million in Penumbra, Inc. $PEN - MarketBeat
S&CO Inc. Takes Position in Penumbra, Inc. $PEN - MarketBeat
Technical Reactions to PEN Trends in Macro Strategies - Stock Traders Daily
Penumbra, Inc.: Financial Data Forecasts Estimates and Expectations | PEN | US70975L1070 - marketscreener.com
Barclays PLC (PEN) discloses 2.34M-share beneficial stake in Penumbra Inc - Stock Titan
Should Penumbra’s RED 68 Catheter Recall and Margin Strain Require Action From Penumbra (PEN) Investors? - webull.com
Penumbra, Inc. (PEN) stock price, news, quote and history - Yahoo Finance Singapore
Penumbra, Inc. (PEN) Stock Price, News, Quote & History - Yahoo! Finance Canada
Washington Trust Advisors, Inc.'s Penumbra Inc(PEN) Holding History - GuruFocus
THUNDER Study Demonstrates Penumbra's THUNDERBOLT is Safe and Effective for Stroke Care - Nonstop Local News Montana
Penumbra, Inc. (PEN) Stock Analysis: Evaluating the 11.45% Potential Upside in Medical Devices - DirectorsTalk Interviews
Penumbra Inc (PEN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Bank of America Corp DE Sells 46,436 Shares of Penumbra, Inc. $PEN - MarketBeat
Royal Bank of Canada Decreases Holdings in Penumbra, Inc. $PEN - MarketBeat
Penumbra Inc (PEN) Stock News Today - TradingKey
The Manufacturers Life Insurance Company Sells 65,658 Shares of Penumbra, Inc. $PEN - MarketBeat
THUNDER study demonstrates Penumbra's Thunderbolt CAVT system is safe and effective for stroke care - Med-Tech Insights
Penumbra, Inc. (PEN) Stock Forecasts - finance.yahoo.com
Penumbra Earnings: Thrombectomy and Embolization Markets Growing by Double Digits - Morningstar
Did Penumbra's (PEN) Voluntary RED 68 Catheter Recall Just Shift Its Investment Narrative? - simplywall.st
California State Teachers Retirement System Purchases 7,800 Shares of Penumbra, Inc. $PEN - MarketBeat
Sei Investments Co. Trims Stock Holdings in Penumbra, Inc. $PEN - MarketBeat
Amundi Buys 259,936 Shares of Penumbra, Inc. $PEN - MarketBeat
Penumbra Stock Price Forecast. Should You Buy PEN? - StockInvest.us
Penumbra (NYSE:PEN) Posts Earnings Results, Misses Expectations By $0.27 EPS - MarketBeat
Penumbra Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Penumbra: Q2 Earnings Snapshot - marketscreener.com
Penumbra, Inc. Reports Second Quarter 2026 Financial Results - Barchart.com
Penumbra Inc earnings missed by $0.28, revenue topped estimates - Investing.com
Penumbra, Inc. Revenue Breakdown – NYSE:PEN - TradingView
85,000 Shares in Penumbra, Inc. $PEN Purchased by Empyrean Capital Partners LP - MarketBeat
Penumbra Releases Results of CAVT System Study for Stroke Patients - dicardiology.com
Penumbra Inc (PEN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Penumbra Inc (PEN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Penumbra Inc (PEN) Income Statement - TradingKey
Penumbra Inc (PEN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Penumbra Inc (PEN) Cash Flow - TradingKey
Penumbra Inc (PEN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Penumbra Inc (PEN) Institutional Confidence - TradingKey
PEN|Penumbra Inc|Price:318.730|Chg%:+0.760 - TradingKey
SummitTX Capital L.P. Acquires New Position in Penumbra, Inc. $PEN - MarketBeat
Penumbra Inc (PEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.76%
0.22%
자본화:
|
볼륨(24시간):